CDC&P - MMWR Vol. 65 / Early Release

MMWR Early Release Vol. 65, Early Release November 29, 2016   PDF   In this report Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs — United States Cyprian Wejnert, PhD; Kristen L. Hess, PhD; H. Irene Hall, PhD; et al. MMWR Morb Mortal Wkly Rep 2016(Early Release) Persons who inject drugs (PWID) are at higher risk for human immunodeficiency virus (HIV) infection, and the U.S. National HIV/AIDS Strategy identifies PWID as a priority population for HIV prevention. Although AIDS diagnoses among PWID have decreased almost 90% since their peak in 1993 and only an estimated 0.3% of the U.S. population has injected drugs in the past 12 months, approximately 9% of HIV infections diagnosed in recent years are among PWID. HIV diagnoses among PWID have decreased over time; however, recent increases in acute hepatitis C virus infections, which are frequently associated with injection drug use, suggest this progress could be negatively affected by increases in opioid and heroin use. Although, decreases in HIV diagnoses among PWID indicate success in HIV prevention, emerging behavioral and demographic trends could reverse this success. MMWR Masthead Department of Health and Human Services Centers for Disease Control and Prevention   The CDC has reached over 1.2 million email subscribers. Thank you for your support. Modify/Update Subscriber Preferences or Unsubscribe | Learn about CDC Updates Questions or problems? Please contact support@govdelivery.com.             This email was sent to mantiskhiralla@gmail.com using GovDelivery, on behalf of: Centers for Disease Control and Prevention • 1600 Clifton Rd • Atlanta, GA 30333 • 1-800-CDC-INFO (800-232-4636)